drugset / Trial / NCT01530269

C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma

NCT01530269

Phase 2 Completed 300 enrolled Phoenix Molecular Imaging
NaSingle-groupOpen-labelDiagnostic

Summary

Positron emission tomography using carbon-11 acetate (AC-PET) may help find local or distant metastases from prostate cancer. This clinical trial is studying how this imaging test may help influence the choice and extent of initial treatments, and subsequent treatments.

Timeline

Start
2012-04
Primary completion
2019-01
Completion
2019-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Acetate Small molecule